On the recordMarch 12, 2014
I believe there should be an avenue for patients to inform the FDA of their opinions about what might be considered for breakthrough.
Source
congress.govI believe there should be an avenue for patients to inform the FDA of their opinions about what might be considered for breakthrough.
Bennet advocates for patient input in the FDA's breakthrough therapy process.
Share & report
More from Hiram Bennet
I want to thank Senators Bennet and Marshall for hosting this and for looking beyond bipartisan lines.
Instead of a dust bowl, today's farmers and ranchers are dealing with a 1,200-year drought.
I would advocate that the creation of a groundwater conservation easement program under ACEP, as envisioned by Senator Bennet.